FDA grants full approval to Pfizer vaccine

On Monday the U.S. Food and Drug Administration (FDA) granted full approval to the Pfizer-BioNTech COVID-19 vaccine for individuals 16 and older. The vaccine, which will be marketed as Comirnaty, also continues to be available under emergency use authorization (EUA) for individuals 12 through 15 years old and for the administration of a third dose in certain immunocompromised individuals.

Schedule vaccination for yourself or your dependents »
Learn more about third doses for immunocompromised individuals »